Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study.
about
Update on the role of eslicarbazepine acetate in the treatment of partial-onset epilepsyRecent treatment advances and novel therapeutic approaches in epilepsyHyponatremia induced by antiepileptic drugs in patients with epilepsy.Highights in the history of epilepsy: the last 200 yearsClinical utility of eslicarbazepine: current evidence.Effects of eslicarbazepine acetate on acute and chronic latrunculin A-induced seizures and extracellular amino acid levels in the mouse hippocampusEslicarbazepine acetate for the treatment of focal epilepsy: an update on its proposed mechanisms of action.Perspectives on treatment options for mesial temporal lobe epilepsy with hippocampal sclerosis.Long-term efficacy and safety of adjunctive extended-release oxcarbazepine (Oxtellar XR® ) in adults with partial-onset seizures.Eslicarbazepine acetate: its effectiveness as adjunctive therapy in clinical trials and open studies.New developments in the management of partial-onset epilepsy: role of brivaracetam.Transition from oxcarbazepine to eslicarbazepine acetate: A single center study.Eslicarbazepine acetate: a review of its use as adjunctive therapy in refractory partial-onset seizures.Pharmacokinetic/pharmacodynamic evaluation of eslicarbazepine for the treatment of epilepsy.A review of the efficacy and safety of eslicarbazepine acetate in the management of partial-onset seizures.Practical Use of Newer Antiepileptic Drugs as Adjunctive Therapy in Focal Epilepsy.Eslicarbazepine acetate for the treatment of partial epilepsy.Eslicarbazepine Acetate: A New Improvement on a Classic Drug Family for the Treatment of Partial-Onset Seizures.Safety, tolerability, and seizure control during long-term treatment with adjunctive brivaracetam for partial-onset seizures.Severe myoclonic epilepsy of infancy: Seizure reduction during adjunctive eslicarbazepine in two casesPharmacokinetics and tolerability of eslicarbazepine acetate and oxcarbazepine at steady state in healthy volunteers.Euro-Esli: a European audit of real-world use of eslicarbazepine acetate as a treatment for partial-onset seizures.Eslicarbazepine acetate in epilepsies with focal and secondary generalised seizures: systematic review of current evidence.Comparing Safety and Efficacy of "Third-Generation" Antiepileptic Drugs: Long-Term Extension and Post-marketing Treatment.Eslicarbazepine acetate in the treatment of adults with partial-onset epilepsy: an evidence-based review of efficacy, safety and place in therapy.Long-term adjunctive lacosamide treatment in patients with partial-onset seizures.
P2860
Q26745780-048A5AB6-96A5-403C-94C5-A7E8E7F4C719Q26824512-5BCA23F6-89E9-44F1-9B57-466E29A86CEBQ30244619-51D56047-2D0A-4A8A-A650-9D97B35243DFQ34151924-57ACF505-ADCE-4F9B-BC74-43766390A610Q35087964-E180753D-A95F-4E34-95B6-FADE022F08B9Q35531026-6BCAAD3C-5DB6-4DF6-B714-A5B0A3085399Q35664957-93CDBF87-7E88-4824-B4DA-268AAABEA550Q35761335-8CFF6951-26C1-4A49-BD15-D940C87A4632Q37295962-90831B93-F0F6-4B33-9D4D-520B8F178468Q37680030-2A6DD60A-55C9-4299-9D6B-D2ABAFD57BFAQ37693757-AAA4ACE9-8CB7-4FFD-A5E6-CD02F250CFD7Q37694387-D259279F-03A4-4AE6-9B9E-886632F6A65FQ38223958-6246F3D2-6BCA-4FCE-BAC9-82D0A37FC035Q38367761-74FDA29C-5AA8-497F-A32D-FACAFCEA14BBQ38542064-6A601187-418D-422E-A54E-6DEE93B1AC73Q38617833-C9509123-C7E1-46E5-8C3A-539417AB687DQ38826584-C58DC1DA-C5F3-4D08-B91E-F38DCD47A2C5Q39456360-FD4C0805-DFA6-4BAC-AC23-3F6833EB232FQ39707630-3C1CB66B-0B19-4E63-8432-E6AC760BD94DQ41507254-EC0BCEF3-07AC-4A15-97E8-7DE16C904AFBQ44062629-387040BA-0201-46E5-BEF8-AC4E38406A34Q44168300-A2FCC16F-30FD-47F1-9D08-944033E9B59CQ47235722-22A2CD1D-18EB-45C2-B3A1-93E48BDF161DQ50075643-1C317ED4-7481-4470-A66F-B7177A10212EQ51736900-B43F439D-2B59-4A0B-A08D-AD0B2CB68D3FQ53444865-0A50859F-096C-43C9-95AF-3138547D2007
P2860
Long-term safety and efficacy of eslicarbazepine acetate as adjunctive therapy in the treatment of partial-onset seizures in adults with epilepsy: results of a 1-year open-label extension study.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh-hant
name
Long-term safety and efficacy ...... ar open-label extension study.
@en
Long-term safety and efficacy ...... ar open-label extension study.
@nl
type
label
Long-term safety and efficacy ...... ar open-label extension study.
@en
Long-term safety and efficacy ...... ar open-label extension study.
@nl
prefLabel
Long-term safety and efficacy ...... ar open-label extension study.
@en
Long-term safety and efficacy ...... ar open-label extension study.
@nl
P2093
P50
P1433
P1476
Long-term safety and efficacy ...... ar open-label extension study.
@en
P2093
Alberto A Gabbai
Andreas Hufnagel
Elinor Ben-Menachem
P304
P356
10.1016/J.EPLEPSYRES.2012.07.014
P577
2012-08-04T00:00:00Z